Chih-Yang Lin Selected Research

Chondrosarcoma

11/2021	Nerve growth factor promotes lysyl oxidase-dependent chondrosarcoma cell metastasis by suppressing miR-149-5p synthesis.
9/2021	WISP-3 Stimulates VEGF-C-Dependent Lymphangiogenesis in Human Chondrosarcoma Cells by Inhibiting miR-196a-3p Synthesis.
8/2021	Visfatin Promotes the Metastatic Potential of Chondrosarcoma Cells by Stimulating AP-1-Dependent MMP-2 Production in the MAPK Pathway.
7/2021	The mir-423-5p/MMP-2 Axis Regulates the Nerve Growth Factor-Induced Promotion of Chondrosarcoma Metastasis.
1/2020	Amphiregulin promotes cisplatin chemoresistance by upregulating ABCB1 expression in human chondrosarcoma.
1/2020	Basic fibroblast growth factor promotes doxorubicin resistance in chondrosarcoma cells by affecting XRCC5 expression.
12/2019	Sphingosine-1-phosphate promotes PDGF-dependent endothelial progenitor cell angiogenesis in human chondrosarcoma cells.
1/2019	An update on current and future treatment options for chondrosarcoma.
1/2018	Resistin facilitates VEGF-C-associated lymphangiogenesis by inhibiting miR-186 in human chondrosarcoma cells.
11/2017	Correction: Amphiregulin enhances alpha6beta1 integrin expression and cell motility in human chondrosarcoma cells through Ras/Raf/MEK/ERK/AP-1 pathway.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chih-Yang Lin Research Topics

Disease

23	Chondrosarcoma 11/2021 - 01/2012
20	Neoplasms (Cancer) 11/2021 - 01/2013
18	Neoplasm Metastasis (Metastasis) 11/2021 - 01/2013
5	Osteoarthritis 06/2022 - 01/2018
3	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 10/2017
2	Inflammation (Inflammations) 01/2020 - 10/2017
2	Lymphatic Metastasis 01/2017 - 06/2016
2	Carcinogenesis 07/2015 - 12/2014
1	Pain (Aches) 04/2022
1	Metatarsal Valgus 04/2022
1	Knee Osteoarthritis 04/2022
1	Metatarsus Varus 04/2022
1	Immune System Diseases (Immune Disorders) 12/2021
1	Rheumatoid Arthritis 12/2021
1	Adenocarcinoma of Lung 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Bone Neoplasms (Bone Cancer) 10/2017
1	Hypoxia (Hypoxemia) 11/2015
1	Body Weight (Weight, Body) 12/2014
1	Purpura 12/2006
1	Gastrointestinal Hemorrhage (Hematochezia) 12/2006

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 12/2021 - 12/2006
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2020 - 01/2012
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2013
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2017 - 10/2014
4	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 06/2022 - 01/2020
4	Vascular Endothelial Growth Factor CIBA 09/2021 - 06/2016
4	ResistinIBA 08/2021 - 01/2018
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2017 - 01/2013
3	Biological ProductsIBA 09/2021 - 07/2015
3	AdipokinesIBA 08/2021 - 12/2014
3	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 08/2021 - 01/2012
3	AmphiregulinIBA 01/2020 - 05/2015
3	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 11/2015 - 10/2014
3	IntegrinsIBA 01/2014 - 01/2012
2	EnzymesIBA 12/2021 - 12/2019
2	Nerve Growth Factor (NGF)IBA 11/2021 - 07/2021
2	Conditioned Culture MediaIBA 09/2021 - 01/2020
2	LeptinIBA 08/2021 - 12/2014
2	AdiponectinIBA 08/2021 - 11/2015
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 08/2021 - 07/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 12/2006
2	Cysteine (L-Cysteine)FDA Link 10/2020 - 10/2017
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2020 - 07/2015
2	sphingosine kinaseIBA 12/2019 - 10/2017
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 12/2019 - 10/2017
2	Integrin alpha6beta1IBA 11/2017 - 05/2015
2	matrigelIBA 11/2015 - 10/2014
2	Nerve Growth Factors (Neurotrophins)IBA 07/2013 - 01/2013
2	trkB ReceptorIBA 07/2013 - 01/2013
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2013 - 01/2013
1	Interleukin-17 (Interleukin 17)IBA 06/2022
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 11/2021
1	human CCN6 proteinIBA 09/2021
1	Transcription Factors (Transcription Factor)IBA 08/2021
1	Nicotinamide PhosphoribosyltransferaseIBA 08/2021
1	Matrix Metalloproteinases (MMPs)IBA 07/2021
1	Insulin-Like PeptidesIBA 01/2021
1	LuciferasesIBA 01/2021
1	Insulin-Like Growth Factor Binding Protein 3IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2020
1	Interleukin-1beta (Interleukin 1 beta)IBA 10/2020
1	CXC ChemokinesIBA 08/2020
1	LigandsIBA 08/2020
1	Phospholipase C betaIBA 08/2020
1	Protein Kinase CIBA 08/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Complementary DNA (cDNA)IBA 12/2019
1	erucylphosphocholineIBA 12/2019
1	Platelet-Derived Growth FactorIBA 12/2019
1	SphingosineIBA 12/2019
1	platelet-derived growth factor AIBA 12/2019
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2019
1	Matrix Metalloproteinase 13IBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Aggrecans (Aggrecan)IBA 01/2018
1	thrombospondin 2IBA 01/2018
1	Angiopoietin-2IBA 10/2017
1	SphingolipidsIBA 10/2017
1	Tissue Inhibitor of Metalloproteinase-3IBA 10/2017
1	Connective Tissue Growth FactorIBA 10/2017
1	Chemokine CCL5IBA 06/2016
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2015
1	TOR Serine-Threonine KinasesIBA 11/2015
1	Adiponectin ReceptorsIBA 11/2015
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 07/2015
1	Biomarkers (Surrogate Marker)IBA 05/2015
1	Bone Morphogenetic Protein 7IBA 01/2014
1	MAP Kinase Kinase Kinase 5IBA 07/2013
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 07/2013
1	U 0126 (UO 126)IBA 01/2012
1	Monoclonal AntibodiesIBA 01/2012
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 01/2012
1	Mitogen-Activated Protein KinasesIBA 01/2012
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2012

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 08/2021 - 10/2017
4	Therapeutics 01/2020 - 10/2014
3	Radiotherapy 01/2020 - 10/2017
1	Physical Therapy Modalities (Physical Therapy Technique) 04/2022